Login / Signup

Ellagic Acid: A Review on Its Natural Sources, Chemical Stability, and Therapeutic Potential.

Javad Sharifi RadCristina QuispeCarla Marina Salgado CastilloRodrigo CarocaMarco A Lazo-VélezHalyna AntonyakAlexandr PolishchukRoman LysiukPetro OliinykLuigi De MasiPaola BontempoMiquel MartorellSevgi Durna DaştanDaniela RiganoMichael WinkWilliam Chi Shing Cho
Published in: Oxidative medicine and cellular longevity (2022)
Ellagic acid (EA) is a bioactive polyphenolic compound naturally occurring as secondary metabolite in many plant taxa. EA content is considerable in pomegranate ( Punica granatum L.) and in wood and bark of some tree species. Structurally, EA is a dilactone of hexahydroxydiphenic acid (HHDP), a dimeric gallic acid derivative, produced mainly by hydrolysis of ellagitannins, a widely distributed group of secondary metabolites. EA is attracting attention due to its antioxidant, anti-inflammatory, antimutagenic, and antiproliferative properties. EA displayed pharmacological effects in various in vitro and in vivo model systems. Furthermore, EA has also been well documented for its antiallergic, antiatherosclerotic, cardioprotective, hepatoprotective, nephroprotective, and neuroprotective properties. This review reports on the health-promoting effects of EA, along with possible mechanisms of its action in maintaining the health status, by summarizing the literature related to the therapeutic potential of this polyphenolic in the treatment of several human diseases.
Keyphrases
  • anti inflammatory
  • healthcare
  • public health
  • endothelial cells
  • emergency department
  • working memory
  • ms ms
  • human health
  • induced pluripotent stem cells
  • neural network